Marker Therapeutics annual free cash flow
2017
2018
2019
Marker Therapeutics Free Cash Flow (FCF) History (MRKR)
Marker Therapeutics reported −$18.7M in free cash flow for fiscal 2019, a decrease of $4.0M from the previous fiscal year, with a free cash flow margin of −8752.25%.
View full Marker Therapeutics company overviewMarker Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-12-31 | −$18.7M | −$4.0M | — | −8752.25% |
| 2018 | 2018-12-31 | −$14.6M | −$6.2M | — | −7100.98% |
| 2017 | 2017-12-31 | −$8.4M | — | — | −4610.10% |
Marker Therapeutics quarterly free cash flow
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2020 | 2020-06-30 | −$5.6M | −$1.3M | — | −1200.20% |
| Q1 2020 | 2020-03-31 | −$4.2M | −$95,595 | — | — |
| Q4 2019 | 2019-12-31 | −$4.6M | $1.7M | — | — |
| Q3 2019 | 2019-09-30 | −$5.7M | −$2.1M | — | — |
| Q2 2019 | 2019-06-30 | −$4.3M | −$1.9M | — | — |
| Q1 2019 | 2019-03-31 | −$4.1M | −$1.8M | — | — |
| Q4 2018 | 2018-12-31 | −$6.3M | — | — | — |
| Q3 2018 | 2018-09-30 | −$3.6M | — | — | — |
| Q2 2018 | 2018-06-30 | −$2.4M | — | — | −1164.70% |
| Q1 2018 | 2018-03-31 | −$2.3M | — | — | — |
Marker Therapeutics free cash flow growth trends
Marker Therapeutics's latest reported quarter, Q2 2020, generated −$5.6M in free cash flow, a decrease of $1.3M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Marker Therapeutics filings at SEC.gov ↗